1Yamano M, Kamato T, Nagakura Y, et al. Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol, 1997,365 : 145-150.
2Chang CS, Lien HC, Yeh HZ, et al. Effect of cisapride on gastric dysrhythmia and emptying of indigestible solids in type-Ⅱ diabetic patients. Scand J Gastroenterol, 1998,33:600-604.
3Tripathi BK. Diabetic gastroparesis. J Assoc Physicians India, 1999,47:1176-1180.
4Kawagishi T, Nishizawa Y, Emoto M, et al. Gastric myoelectrical activity in patients with diabetes. Role of glucose control and autonomic nerve function. Diabetes Care, 1997,20:848-854.
5Cucchiara S, Franzese A, Salvia G, et al. Gastric emptying delay ant igastric electrical derangement in IDDM. Diabetes Care, 1998,21:438-443.
6Soykan I, Lin Z, Sarosiek 1, et al. Gastric myoelectrical activity,gastric emptying, and correlations with symptoms and fasting blood glucose levels in diabetic patients. Am J Med Sci, 1999,317:226-231.
7Durra V, Padhy AK, Ahuja V, et al. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics. Trop Gastroenterol,1999,20 : 116-119.
8Richards RD, Valenzuela GA, Davenport KG, et al. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis. Dig Dis Sci, 1993,38:811-816.
9Bran S, Murray WA, Hirsch IB, et al. Long QT syndrome during highdose cisapride. Arch Intern Med, 1995,155:765-768.
10Borovicka J, Lehmann R, Kunz P, et al. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging:effects of cisapride. Am J Gastroenterol, 1999,94:2866-2873.
